Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis

This study has been completed.
Sponsor:
Information provided by:
XOMA (US) LLC
ClinicalTrials.gov Identifier:
NCT00051662
First received: January 14, 2003
Last updated: June 23, 2005
Last verified: September 2004
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: February 2004
  Estimated Primary Completion Date: No date given